Hot Features
| Actionnaire | Type | Détenues (Réel) | % en Circulation | Valeur Marchande | Date de Reporte |
|---|---|---|---|---|---|
| Janus Henderson Group plc | Institution | 1 284 324 | 13,09% | US$ 95,58M | 2026-03-31 |
| Mr. Ian McDonald | Initiés | 1 004 900 | 10,24% | US$ 74,78M | 2025-09-30 |
| Janus Henderson Biotech Innovation Master Fund Limited | Institution | 984 485 | 10,03% | US$ 73,27M | 2025-03-31 |
| Cormorant Asset Management, LP | Institution | 950 000 | 9,68% | US$ 70,70M | 2026-04-28 |
| Cormorant Global Healthcare Master Fund, LP | Institution | 950 000 | 9,68% | US$ 70,70M | 2026-04-28 |
| BlackRock, Inc. | Institution | 621 933 | 6,34% | US$ 46,28M | 2026-03-31 |
| Vivo Capital, LLC | Institution | 557 172 | 5,68% | US$ 41,46M | 2026-03-31 |
| Braidwell LP | Institution | 539 708 | 5,50% | US$ 40,17M | 2026-03-31 |
| Vivo Opportunity Fund Holdings, L.P | Institution | 504 645 | 5,14% | US$ 37,56M | 2026-03-31 |
| Adage Capital Management, L.P. | Institution | 495 743 | 5,05% | US$ 36,89M | 2026-03-31 |
| Vestal Point Capital, LP | Institution | 492 319 | 5,02% | US$ 36,64M | 2026-03-31 |
| Dr. Alan Kozikowski | Initiés | 480 500 | 4,90% | US$ 35,76M | 2024-12-20 |
| Perceptive Life Sciences Master Fund, Ltd. | Institution | 449 290 | 4,58% | US$ 33,44M | 2025-12-31 |
| Driehaus Capital Management LLC | Institution | 432 515 | 4,41% | US$ 32,19M | 2026-03-31 |
| Adage Capital Partners, L.P. | Institution | 395 743 | 4,03% | US$ 29,45M | 2025-09-30 |
| Perceptive Advisors LLC | Institution | 377 544 | 3,85% | US$ 28,10M | 2026-03-31 |
| Commodore Capital Master LP | Institution | 351 848 | 3,59% | US$ 26,18M | 2024-12-31 |
| Balyasny Asset Management L.P. | Institution | 297 158 | 3,03% | US$ 22,11M | 2026-03-31 |
| Deerfield Management Company, L.P. | Institution | 283 000 | 2,88% | US$ 21,06M | 2026-03-31 |
| RA Capital Management, L.P. | Institution | 265 000 | 2,70% | US$ 19,72M | 2026-03-31 |
| Great Point Partners, LLC | Institution | 220 000 | 2,24% | US$ 16,37M | 2026-03-31 |
| MPM BioImpact LLC | Institution | 212 175 | 2,16% | US$ 15,79M | 2026-03-31 |
| RA Capital Healthcare Fund, L.P. | Institution | 206 427 | 2,10% | US$ 15,36M | 2025-03-31 |
| Ikarian Capital, LLC | Institution | 166 647 | 1,70% | US$ 12,40M | 2026-03-31 |
| Wellington Management Group LLP | Institution | 136 677 | 1,39% | US$ 10,17M | 2026-03-31 |
| Eventide Asset Management, LLC | Institution | 130 013 | 1,33% | US$ 9,68M | 2026-03-31 |
| Morgan Stanley | Institution | 127 360 | 1,30% | US$ 9,48M | 2026-03-31 |
| Seven Grand Managers LLC | Institution | 120 000 | 1,22% | US$ 8,93M | 2026-03-31 |
| Acuta Capital Partners, LLC | Institution | 111 996 | 1,14% | US$ 8,33M | 2026-03-31 |
| State Street Global Advisors, Inc. | Institution | 108 239 | 1,10% | US$ 8,06M | 2026-03-31 |
| Logos Global Master Fund, LP | Institution | 100 000 | 1,02% | US$ 7,44M | 2024-10-16 |
| Geode Capital Management, LLC | Institution | 88 716 | 0,90% | US$ 6,60M | 2026-03-31 |
| Sio Capital Management, LLC | Institution | 86 083 | 0,88% | US$ 6,41M | 2026-03-31 |
| The B Group, Inc. | Institution | 67 500 | 0,69% | US$ 5,02M | 2026-03-31 |
| Vanguard Portfolio Management, LLC | Institution | 60 482 | 0,62% | US$ 4,50M | 2026-03-31 |
| Dr. Jan Pedersen | Initiés | 57 600 | 0,59% | US$ 4,29M | 2025-09-30 |
| Walleye Capital LLC | Institution | 53 706 | 0,55% | US$ 4,00M | 2026-03-31 |
| Millennium Management LLC | Institution | 52 832 | 0,54% | US$ 3,93M | 2026-03-31 |
| Vivo Opportunity Cayman Fund,L.P. | Institution | 52 527 | 0,54% | US$ 3,91M | 2026-03-31 |
| Boothbay Fund Management, LLC | Institution | 51 290 | 0,52% | US$ 3,82M | 2026-03-31 |
| Columbia Management Investment Advisers, LLC | Institution | 50 027 | 0,51% | US$ 3,72M | 2026-03-31 |
| The Goldman Sachs Group, Inc. | Institution | 45 965 | 0,47% | US$ 3,42M | 2026-03-31 |
| Woodline Partners LP | Institution | 45 668 | 0,47% | US$ 3,40M | 2026-03-31 |
| Parkman Healthcare Partners LLC | Institution | 40 098 | 0,41% | US$ 2,98M | 2026-03-31 |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.